BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan KS, Heiss JD, Brown SM, Collins MT, Boyce AM. Chiari I Malformation and Basilar Invagination in Fibrous Dysplasia: Prevalence, Mechanisms, and Clinical Implications. J Bone Miner Res 2018;33:1990-8. [PMID: 29924878 DOI: 10.1002/jbmr.3531] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Sato K, Tsunoda K, Matsuo T. Long-term imaging course of Chiari malformation type I due to fibrous dysplasia/McCune-Albright syndrome. Childs Nerv Syst 2022. [PMID: 35790572 DOI: 10.1007/s00381-022-05472-0] [Reference Citation Analysis]
2 Xue J, Jia K, Li T, Zhang J, An J. GNAS mutation analysis assists in differentiating chronic diffuse sclerosing osteomyelitis from fibrous dysplasia in the jaw. Mod Pathol. [DOI: 10.1038/s41379-022-01103-w] [Reference Citation Analysis]
3 Abdallah HM, Fernandes Cabral DT, Gersey ZC, Abou-Al-Shaar H, O'keefe S, Mysels S, John I, Gardner PA, Solari MG, Zenonos GA. Reduction of giant parietooccipital fibrous dysplasia using dynamic mirror image guidance: a case report and review of the literature. Br J Neurosurg 2022;:1-7. [PMID: 35445637 DOI: 10.1080/02688697.2022.2061422] [Reference Citation Analysis]
4 Rosenblum JS, Pomeraniec IJ, Heiss JD. Chiari Malformation (Update on Diagnosis and Treatment). Neurologic Clinics 2022. [DOI: 10.1016/j.ncl.2021.11.007] [Reference Citation Analysis]
5 Welborn MC, Sanders JO. Spinal Deformity in Metabolic Disorders. The Growing Spine 2022. [DOI: 10.1007/978-3-030-84393-9_21] [Reference Citation Analysis]
6 刘 文. Multiple Fibrous Dysplasia of the Clivus and Occipital Bone: A Case Report and Literature Review. ACM 2022;12:798-803. [DOI: 10.12677/acm.2022.122116] [Reference Citation Analysis]
7 Alexiou G, Kafritsas G, Prodromou N. Scalp and Skull Tumors. Pediatric Neurosurgery for Clinicians 2022. [DOI: 10.1007/978-3-030-80522-7_16] [Reference Citation Analysis]
8 Geels RES, Meier ME, Saikali A, Tsonaka R, Appelman-Dijkstra NM, Boyce AM. Long Bone Fractures in Fibrous Dysplasia/McCune-Albright Syndrome: Prevalence, Natural History, and Risk Factors. J Bone Miner Res 2021. [PMID: 34668234 DOI: 10.1002/jbmr.4463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Theng EH, German A, Pan KS, Isaac S, Boyce AM, Collins MT. Periorbital inflammation associated with craniofacial fibrous dysplasia: Report of three cases and review of the literature. Bone 2021;153:116157. [PMID: 34425287 DOI: 10.1016/j.bone.2021.116157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Boyce AM, Collins MT. Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation. Endocr Rev 2020;41:bnz011. [PMID: 31673695 DOI: 10.1210/endrev/bnz011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
11 Gladding A, Szymczuk V, Auble BA, Boyce AM. Burosumab treatment for fibrous dysplasia. Bone 2021;150:116004. [PMID: 33984553 DOI: 10.1016/j.bone.2021.116004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Sweeney K, Kaban LB. Natural History and Progression of Craniofacial Fibrous Dysplasia: A Retrospective Evaluation of 114 Patients From Massachusetts General Hospital. Journal of Oral and Maxillofacial Surgery 2020;78:1966-80. [DOI: 10.1016/j.joms.2020.05.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Raborn LN, Pan KS, FitzGibbon EJ, Collins MT, Boyce AM. Optic disc edema in fibrous dysplasia/McCune-Albright syndrome: Prevalence, etiologies, and clinical implications. Bone 2021;143:115661. [PMID: 32979536 DOI: 10.1016/j.bone.2020.115661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pan KS, FitzGibbon EJ, Vitale S, Lee JS, Collins MT, Boyce AM. Utility of Optical Coherence Tomography in the Diagnosis and Management of Optic Neuropathy in Patients with Fibrous Dysplasia. J Bone Miner Res 2020;35:2199-210. [PMID: 32644197 DOI: 10.1002/jbmr.4129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Rosenblum JS, Cappadona AJ, Argersinger DP, Pang Y, Wang H, Nazari MA, Munasinghe JP, Donahue DR, Jha A, Smirniotopoulos JG, Miettinen MM, Knutsen RH, Kozel BA, Zhuang Z, Pacak K, Heiss JD. Neuraxial dysraphism in EPAS1-associated syndrome due to improper mesenchymal transition. Neurol Genet 2020;6:e414. [PMID: 32337341 DOI: 10.1212/NXG.0000000000000414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 de Castro LF, Ovejero D, Boyce AM. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome. Eur J Endocrinol 2020;182:R83-99. [PMID: 32069220 DOI: 10.1530/EJE-19-0969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Spencer T, Pan KS, Collins MT, Boyce AM. The Clinical Spectrum of McCune-Albright Syndrome and Its Management. Horm Res Paediatr 2019;92:347-56. [PMID: 31865341 DOI: 10.1159/000504802] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
18 Neromyliotis E, Sapountzi M, Nikas I, Karydakis P, Mitsios A, Sfakianos G, Themistocleous MS. Fibrous dysplasia of occipital and temporal bone. A case report. Oxf Med Case Reports 2019;2019:omz039. [PMID: 31198575 DOI: 10.1093/omcr/omz039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 2019;14:139. [PMID: 31196103 DOI: 10.1186/s13023-019-1102-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 19.0] [Reference Citation Analysis]
20 Hartley I, Zhadina M, Collins MT, Boyce AM. Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review. Calcif Tissue Int 2019;104:517-29. [PMID: 31037426 DOI: 10.1007/s00223-019-00550-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
21 Rotman M, Hamdy NAT, Appelman-Dijkstra NM. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone. Br J Clin Pharmacol 2019;85:1169-79. [PMID: 30471134 DOI: 10.1111/bcp.13820] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]